DuxLegis USA supports life sciences innovators with USPTO patent prosecution, Orange Book strategy, Hatch-Waxman awareness, and trademark protection for brands and devices.
Patent term extension, biosimilar litigation, and FDA exclusivity require coordinated IP and regulatory planning.
DuxLegis USA serves clients in Maryland, Washington DC, and clients nationwide.